ODIN

Aarhus University Seal
 AU Research  Projects ODIN FRIGG

The FRIGG project team aims to model the early stages of Chronic Kidney Disease (CKD). In collaboration with their industry partners from AstraZeneca, Nordic Bioscience and Novo Nordisk, they will use fresh human kidney tissue to identify new biomerkers and therapeutic targets.

On this page, you can find all of the news from ODIN, which is related to the FRIGG project. If you are curious about the project and would like to know more, please contact Heads of the project Lene N. Nejsum or Rikke Nørregaard.

FRIGG is short for "FResh Human KIdney Tissue: ExplorinG biomarkers and intervention tarGets in chronic kidney disease" 

Main contacts for the FRIGG project

Rikke Nørregaard

Professor
M

P +4520862000

Lene Niemann Nejsum

Professor
M

P +4521163121

Companies involved in the FRIGG project

Mice are (no longer) a model for human Chronic Kidney Disease

- FRIGG

If you’re reading this, you’re not a mouse.

 

In some cases, we might play pretend, though. Cases such as when we use mice as animal models for…

Current status of the FRIGG project

- FRIGG

The FRIGG project ultimately aims to improve life quality for patients with chronic kidney disease (CKD). Here, Lene N. Nejsum and Rikke Nørregaard,…

Introducing the FRIGG project

- FRIGG

This video introduces the FRIGG team and explains why and how they aim to develop a new model for Chronic Kidney Disease. The project includes…

AstraZeneca - Industry Partner in FRIGG

- FRIGG

Timo Haschler is a Senior Scientists in the Bioscience Renal division at AstraZeneca. He is an industry partner in FRIGG, and here he explains why it…

AstraZeneca - Industry partner in FRIGG

- FRIGG

Pernille B. Lærkegaard Hansen is an Executive Director at AstraZeneca and Head of the Bioscience Renal division. Here she explains why she believes…

Nordic Bioscience - industry partner in FRIGG

- FRIGG

Federica Genovese is Director at the department of Cardiovascular and Renal Research at Nordic Bioscience. Here, she explains why Nordic Bioscience…

Better and cheaper drugs in less time: Aarhus University and industry are joining forces in six new open research collaboration projects

- ODINcall2

ODIN has reserved DKK 23.9 million for six new research projects that will pave the way for new drugs to treat a wide range of medical conditions –…

Meet the FRIGG team

- FRIGG

Chronic kidney disease (CKD) is a growing cause of global mortality. Yet, pre-clinical research and drug development are hampered by the lack of good…

Aim of the FRIGG project

- FRIGG

FRIGG is an open collaboration between AU researchers and industry representatives from AstraZeneca, Nordic Bioscience, and Novo Nordisk. Their aim is…

Our OPEN approach to innovation in science

In ODIN, all findings and results will be shared openly. 

Researchers working on ODIN projects are encouraged to upload all of their findings to the ODIN community on Zenodo - see the link to the right.

If you have any questions, you are more than welcome to contact the ODIN secretariat.

Articles and results from ODIN projects
Revised 07.11.2023
-
Ditte Høyer Engholm